MIPS Program Impact
Historical Impact Data
705
Maryland companies have used MIPS to develop products through 1,003 projects
14,000
Current, direct jobs created
27,000
Total jobs supported
$52.7B
Revenue from top MIPS-supported products
63%
Of ALL startups funded by MIPS since 1987 are still in business today
87%
Of MIPS-funded startups still in business five years later
$125M
Annual tax revenues to counties from MIPS companies
$166M
Annual tax revenues to the state from MIPS companies
41 to 1
Cumulative return on investment to the state, per MIPS dollar
MIPS Company Videos
Hughes Network Systems
MedImmune/AstraZeneca
Martek Biosciences
WellDoc
Gel-e/Medcura
Leading Products Aided by MIPS Projects
Life's DHA, by Martek Biosciences, Columbia, MD
- Martek produced and sold nutritional oils, primarily DHA, which were added to infant formula and other foods.
- The company’s oils were made from algae.
Martek was acquired by Royal DSM for $1.1B. - The company has retained a presence in Columbia, Md.
- Martek generated $2.9B in revenue before its acquisition.
- At one point, Martek supplied DHA to infant formula companies collectively representing 75 percent of the estimated $15 billion worldwide retail market for infant formula and nearly 100 percent of the estimated $4.5 billion U.S. retail market for infant formula.
- Over 200 domestic and international companies launched non-infant formula products that contain Martek’s DHA product.
HughesNet, by Hughes Network Systems, Germantown, MD
- HughesNet is the world's leading broadband by satellite service. Formerly called DirecWAY, DirectPC.
- $31.2B in revenue
- Acquired by EchoStar for $2B
- More than 2 million systems ordered or shipped to customers in 100 countries
- System based on breakthrough algorithms designed by John Baras, UMD Professor, under MIPS funding
Synagis, by MedImmune/AstraZeneca, Gaithersburg, MD
- MedImmune’s first major product, Synagis, received crucial support from MIPS projects in the early, pre-market days of the company.
- Synagis is a vaccine for RSV.
- Synagis has $18B in total sales to date.
- Bowie State MIPS projects helped secure patents on Synagis.
- UMBC projects helped achieve FDA approval of the Synagis manufacturing process.
- MedImmune was acquired by AstraZeneca for $15.6B and stayed and grew in Maryland.
- AstraZeneca has created 10,000 jobs in Maryland
WellDoc Digital Health Platform, by WellDoc, Columbia, MD
- Revolutionary mobile health system for chronic diseases
- FDA-approved diabetes manager system
- 106 employees; started with three employees at a time of crucial first outside funding, which came from MIPS
- UMB MIPS project: clinical trial of WellDoc’s mobile health system
- Trial showed major benefits for diabetes patients
- Enabled WellDoc to acquire FDA approval
Browse a special collection of MIPS projects in the 30th anniversary collection
